Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Seres Therapeutics (MCRB) Asset Utilization Ratio: 2016-2025

Historic Asset Utilization Ratio for Seres Therapeutics (MCRB) over the last 7 years, with Sep 2025 value amounting to 0.00.

  • Seres Therapeutics' Asset Utilization Ratio was N/A to 0.00 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.00, marking a year-over-year change of. This contributed to the annual value of 0.36 for FY2023, which is 1662.86% up from last year.
  • As of Q3 2025, Seres Therapeutics' Asset Utilization Ratio stood at 0.00, which was down 99.79% from 0.36 recorded in Q1 2024.
  • In the past 5 years, Seres Therapeutics' Asset Utilization Ratio registered a high of 0.47 during Q3 2021, and its lowest value of 0.00 during Q3 2025.
  • Moreover, its 3-year median value for Asset Utilization Ratio was 0.34 (2023), whereas its average is 0.24.
  • In the last 5 years, Seres Therapeutics' Asset Utilization Ratio slumped by 95.23% in 2023 and then soared by 1,713.23% in 2024.
  • Over the past 5 years, Seres Therapeutics' Asset Utilization Ratio (Quarterly) stood at 0.39 in 2021, then slumped by 94.41% to 0.02 in 2022, then surged by 1,525.37% to 0.35 in 2023, then spiked by 1,713.23% to 0.36 in 2024, then reached 0.00 in 2025.
  • Its Asset Utilization Ratio stands at 0.00 for Q3 2025, versus 0.36 for Q1 2024 and 0.35 for Q4 2023.